|
KMID : 0377619970620050422
|
|
Korean Jungang Medical Journal
1997 Volume.62 No. 5 p.422 ~ p.422
|
|
|
Future Therapies and the Role of High Technology in the Treatment of Patients with Gynecologic Malignancies
|
|
Wharton, J. Taylor
|
|
|
Abstract
|
|
|
During the past two decades investigators have made tremendous progress in defining the basic molecular process involved in normal and abnormal cell growth. Future diagnostic tests and therapies will be sensitive and specific enough to detect and correct genetic abnormalities in their earliest expression. Abnormalities in stimulator- pathways, receptor genes, cytoplasm relay proteins, transcription factors and inhibitory pathways will provide molecular targets for future treatment modalities. The detection and correction of abnormal suppressor genes such as p53 is one exam )le.
Conventional therapies such as surgery, chemotherapy, and radiation therapy will be enhanced by new technologies. Bone marrow transplantation or "stem cell treatment" will be properly defined and drug resistance will be better understood. Three-dimensional imaging will replace the conventional CT scan and sonogram. The use of advanced computer technology and "virtual reality" will change the learning process, graduate and postgraduate education, and recertification. Global telecommunication through satellite links will allow rapid exchange of information and ideas. Medicine and therapies in the next century will have few similarities with today´s standards.
|
|
|
KEYWORD
|
|
|
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|